NOTIFICATION OF THE REMOVAL FROM LISTING AND
REGISTRATION OF THE STATED SECURITIES

NYSE Amex hereby notifies
the SEC of its intention to remove
the entire class of the stated securities
from listing and registration on the
Exchange at the opening of business on
July 16, 2010, pursuant to the provisions
of Rule 12d2-2 (a) 17CFR240.12d2-2(a)(3)

The removal of Javelin Pharmaceuticals, Inc.,
Common Stock, $.001 par value is being
effected because the Exchange knows or is
reliably informed that on July 2, 2010 the
instruments representing the securities
comprising the entire class of this security
came to evidence, by operation of law or
otherwise, other securities in substitution
therefore and represent no other right
except, if such be the fact, the right
to receive an immediate cash payment.


The security was suspended by the
Exchange on July 6, 2010.